Oracle Alpha Inc. Novo Cure LTD Transaction History
Oracle Alpha Inc.
- $55.7 Billion
- Q1 2024
A detailed history of Oracle Alpha Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Oracle Alpha Inc. holds 15,367 shares of NVCR stock, worth $223,436. This represents 0.43% of its overall portfolio holdings.
Number of Shares
15,367
Previous 12,767
20.37%
Holding current value
$223,436
Previous $191 Million
26.01%
% of portfolio
0.43%
Previous 0.25%
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
272Shares Held
77.1MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$176 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$170 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$162 Million0.0% of portfolio
-
State Street Corp Boston, MA3.01MShares$43.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.38MShares$34.5 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.53B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...